Editas Medicine, Inc. - COM (EDIT)

Historical Portfolio Holders from Q1 2016 to Q2 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
67.6 M
Holdings value Q1 2024
$501 M
Value change Q1 2024
+$62 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
216
Number of buys Q1 2024
105
Number of sells Q1 2024
-93
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
28106W103
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 1.52 K $7.09 K +$3.7 K $4.67 1
2024 Q1 67.9 M $504 M +$62 M $7.42 218
2023 Q4 58.5 M $593 M -$28.2 M $10.13 221
2023 Q3 61.3 M $478 M -$11.8 M $7.80 214
2023 Q2 62.2 M $512 M +$80.2 M $8.23 227
2023 Q1 52.9 M $384 M -$11.2 M $7.25 226
2022 Q4 53.5 M $475 M +$42.7 M $8.87 239
2022 Q3 48.2 M $590 M +$10.1 M $12.24 242
2022 Q2 47.4 M $560 M +$912 K $11.83 232
2022 Q1 45 M $856 M -$136 M $19.02 235
2021 Q4 50.8 M $1.35 B -$57.2 M $26.55 287
2021 Q3 51.5 M $2.12 B -$9.82 M $41.08 304
2021 Q2 52.1 M $2.96 B -$26.5 M $56.64 310
2021 Q1 51.4 M $2.16 B +$4.9 M $42.00 290
2020 Q4 52.9 M $3.71 B -$146 M $70.11 303
2020 Q3 55.1 M $1.55 B +$15.9 M $28.06 230
2020 Q2 54.3 M $1.61 B +$264 M $29.58 226
2020 Q1 45.5 M $902 M -$8.81 M $19.83 182
2019 Q4 45.5 M $1.35 B +$25.7 M $29.61 213
2019 Q3 44 M $1 B +$119 M $22.74 172
2019 Q2 39.7 M $982 M +$65.8 M $24.74 182
2019 Q1 37.4 M $914 M +$73.8 M $24.45 190
2018 Q4 34.5 M $784 M +$24.1 M $22.75 186
2018 Q3 32.7 M $1.04 B +$36.3 M $31.82 192
2018 Q2 32 M $1.15 B +$41 M $35.83 208
2018 Q1 30.9 M $1.03 B +$24.6 M $33.15 197
2017 Q4 30.2 M $929 M +$77.9 M $30.73 143
2017 Q3 27.2 M $652 M +$40.3 M $24.01 115
2017 Q2 25.8 M $433 M +$21.1 M $16.78 107
2017 Q1 27.5 M $614 M +$121 M $22.32 98
2016 Q4 23.5 M $381 M +$22.2 M $16.23 83
2016 Q3 22.2 M $299 M +$9.01 M $13.48 70
2016 Q2 17.6 M $429 M -$15.1 M $24.40 65
2016 Q1 18.2 M $625 M +$464 M $34.54 48